SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-017036
Filing Date
2017-08-09
Accepted
2017-08-09 17:16:26
Documents
54
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q toca-10q_20170630.htm 10-Q 1783112
2 EX-10.1 toca-ex101_331.htm EX-10.1 32389
3 EX-31.1 toca-ex311_7.htm EX-31.1 8890
4 EX-31.2 toca-ex312_6.htm EX-31.2 8611
5 EX-32.1 toca-ex321_8.htm EX-32.1 6427
  Complete submission text file 0001564590-17-017036.txt   6835287

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT toca-20170630.xml EX-101.INS 1625448
7 XBRL TAXONOMY EXTENSION SCHEMA toca-20170630.xsd EX-101.SCH 39852
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE toca-20170630_cal.xml EX-101.CAL 43943
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE toca-20170630_def.xml EX-101.DEF 161081
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE toca-20170630_lab.xml EX-101.LAB 348987
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE toca-20170630_pre.xml EX-101.PRE 274190
Mailing Address 3030 BUNKER HILL STREET, SUITE 230 SAN DIEGO CA 92109
Business Address 3030 BUNKER HILL STREET, SUITE 230 SAN DIEGO CA 92109 (858) 412-8400
Tocagen Inc (Filer) CIK: 0001419041 (see all company filings)

IRS No.: 261243872 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38052 | Film No.: 171018880
SIC: 2834 Pharmaceutical Preparations